VMET

Versamet Royalties Corporation Common Stock
NASDAQBASIC MATERIALSOTHER PRECIOUS METALS & MINING

Key Statistics

Market Cap
$1.03B
P/E Ratio
30.45
EPS
$0.31
Beta
52W High
$15.00
52W Low
$9.10
50-Day MA
$12.02
200-Day MA
$11.51
Dividend Yield
Profit Margin
58.40%
Forward P/E
48.08
PEG Ratio

About Versamet Royalties Corporation Common Stock

Viamet Pharmaceuticals Corp (VMET) is a biopharmaceutical company focused on developing cutting-edge therapeutics for serious diseases, leveraging its proprietary metalloenzyme-based technology platform. The company is committed to addressing significant unmet medical needs in fungal infections and oncology, positioning itself as a leader in therapeutic innovation. With a diverse pipeline bolstered by strategic collaborations and a strong intellectual property portfolio, Viamet is well-prepared to advance its clinical initiatives and enhance shareholder value, aiming to redefine treatment approaches in its specialized therapeutic areas.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$55.27M
Gross Profit (TTM)$37.23M
EBITDA$67.34M
Operating Margin90.60%
Return on Equity11.20%
Return on Assets10.90%
Revenue/Share (TTM)$0.58
Book Value$3.46
Price-to-Book3.50
Price-to-Sales (TTM)18.55
EV/Revenue23.88
EV/EBITDA18.81
Quarterly Earnings Growth (YoY)573.00%
Quarterly Revenue Growth (YoY)594.00%
Shares Outstanding$108.59M
Float$28.81M
% Insiders75.32%
% Institutions7.84%

Historical Volatility

HV 10-Day
98.58%
HV 20-Day
85.28%
HV 30-Day
77.88%
HV 60-Day
82.36%
HV Rank

Volatility is currently expanding

Latest News

Versamet Royalties Announces Results of Annual General and Special Meeting of Shareholders

Vancouver, British Columbia--(Newsfile Corp. - June 29, 2026) - Versamet Royalties Corporation (NASDAQ: VMET) (TSX: VMET) ("Versamet" or the "Company") is pleased to announce that all matters presented for approval at Versamet's annual general and special meeting of shareholders held today, as more particularly set out in the Company's Management Information Circular dated May 19, 2026 (the "Circular"), have been approved. These matters included: appointing PricewaterhouseCoopers LLP, Chartered Professional Accountants, as auditors of the Company until the next annual general meeting and authorising the board of directors to set their remuneration; electing directors of the Company for the ensuing year; approving a special resolution, the full text of which is set forth in the Circular, adopting certain amendments to the articles of the Company; and approving an ordinary resolution, the full text of which is set forth in the Circular, adopting certain amendments to the Company's omnibus equity incentive plan dated September 1, 2022.

Newsfile Corp6/29/2026Neutral
Versamet Royalties Completes Acquisition of Cornerstone Canadian Gold Stream on Eskay Creek

All amounts are in U.S. dollars unless otherwise indicated. Vancouver, British Columbia--(Newsfile Corp. - April 10, 2026) - Versamet Royalties Corporation  (NASDAQ: VMET) (TSX: VMET) ("Versamet" or the "Company") has completed the previously announced acquisition of a 3.52% gold stream (the "Gold Stream") in respect of gold production from the Eskay Creek gold-silver project ("Eskay" or the "Project") from fund entities managed by Orion Resource Partners LP and fund entities managed by affiliates of Blackstone Inc. (collectively, the "Vendors").

Newsfile Corp4/10/2026Neutral

More BASIC MATERIALS Stocks

Data last updated: 7/9/2026